×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2026年會
摘要
2026半年會
摘要
2025年會 (UAA)
摘要
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
熱門媒體
熱門媒體
(
最新
)
熱門媒體
(
最新
)
MP098: Different laparoscopic partial cystectomy approach for bladder leiomyoma
1871 觀看
NDP08: Elective radical prostatectomy for huge prostate cancer with bilateral obstructive uropathy、rectal invasion and oligometastasis of bone
1870 觀看
MP087: Outcomes of laparoscopic and robotic nephroureterectomy approaches in patients with T3 and T4 upper tract urothelial carcinoma in CMUH
1870 觀看
PD4-2: Tumor-originated exosomal prothymosin-α triggers muscle wasting in bladder cancers
1869 觀看
MP027: Robotic partial nephrectomy for > 4cm renal cell carcinoma: single center experience
1869 觀看
NDP037: Lower urinary tract symptoms caused by Müllerian duct cyst: A case report
1868 觀看
MP01-10: MCTP1 promotes SNAI1-driven neuroendocrine differentiation and epithelial-to-mesenchymal transition of prostate cancer enhancement by ZBTB46/FOXA2/HIF1A
1868 觀看
PD8-6: Regular cystoscopy-assisted bladder toilet is beneficial in catheter-associated urinary tract infection
1867 觀看
MP021: Real world experience of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer
1867 觀看
MP07-10: Hypertension as a risk factor for urinary retention in the acute stage of the middle cerebral artery stroke
1867 觀看
MP034: Comparison between complete response of trimodality therapy and neoadjuvant chemotherapy with radical cystectomy in muscle invasive bladder cancer - CMUH experience
1865 觀看
PD02-3: Association between statin use and clinical outcomes in patients with de novo metastatic prostate cancer: A propensity score-weighted analysis
1865 觀看
MP083: An immune checkpoint inhibitor as neoadjuvant therapy in patients with bladder urothelial carcinoma: preliminary experiences in a single institute
1863 觀看
MP15: Laser Flow Cytometry UF-1000i is useful in predicting therapeutic outcomes in women with uncomplicated urinary tract infections
1863 觀看
MP30: The study of growth inhibition and MDR modulation of bladder cancer by ellagic acid combination with chemotherapeutics
1862 觀看
PD05-2: Effect of nocturia in patients with different severity of obstructive sleep apnea on polysomnography
1862 觀看
MP066: Infection after transrectal ultrasound-guided prostate biopsy - rate and contributing factors at a regional hospital
1861 觀看
PD5-1: Using the novel “structural equation modeling” to analyze factors and pathways on the development of uric acid nephrolithiasis
1860 觀看
NDP033: Radium-223 for mCRPC: Real-world experience of a single-center
1859 觀看
PD07-1: High Transaldolase 1 (TALDO1) expression predicts poor survival of upper tract urothelial carcinoma patients
1858 觀看
PD02-5: Intracavernous injection of autologous platelet-rich plasma ameliorated hyperlipidemia-associated erectile dysfunction in a rat model
1858 觀看
PD04-2: Optimal sequencing treatment in castration resistance prostate cancer—A retrospective study in Kaohsiung Chang Gung Memorial Hospital
1858 觀看
MP36: Evaluation of the impact of shock wave lithotripsy on kidneys using neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, and 3-nitrotyrosine
1857 觀看
PD04-02: Overall survival with Darolutamide versus placebo in combination with androgen-deprivation therapy and Docetaxel for metastatic hormone-sensitive prostate cancer in the phase 3 ARASENS trial
1857 觀看
<
77
78
79
80
81
82
83
84
85
86
>
/ 163